Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The provision of a time-critical elective surgical service during the COVID-19 Crisis: a UK experience.

Annals of the Royal College of Surgeons of England·2021

Same author

Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains.

Acta neuropathologica·2021

Same author

Arthroscopic subtalar arthrodesis through the sinus tarsi portal approach: A series of 77 cases.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2018

Same author

Identification of delirium and dementia in older medical inpatients in Tanzania: A comparison of screening and diagnostic methods.

Journal of the neurological sciences·2018

Same author

Decortication and osteotomy for the correction of multiplanar deformity in the treatment of malunion in adult diaphyseal femoral deformity: a case series and technique description.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2017

Same author

The prenatal gut microbiome: are we colonized with bacteria in utero?

Pediatric obesity·2017

Search research articles

Related Experiment Video

Updated: Feb 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Childhood medulloblastoma.

R W Walker¹, M K Rosenblum

¹Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Revue Neurologique

|January 1, 1992

Summary

Treatment for medulloblastoma has improved, with survival rates exceeding 75% for lower-risk patients. However, late treatment effects necessitate focusing on reduced radiation doses, especially for younger patients.

Area of Science:

Pediatric Oncology
Neuro-oncology
Radiation Oncology

Background:

Medulloblastoma treatment has seen significant progress, improving survival rates.
Current treatments, while effective, can lead to deleterious late effects in patients.
Advanced neuroimaging and reduced surgical mortality have enhanced early diagnosis and intervention.

Purpose of the Study:

To review the advancements in medulloblastoma treatment.
To highlight the trade-off between survival gains and treatment side effects.
To advocate for reduced neuraxis radiation doses in specific patient populations.

Main Methods:

Review of current treatment modalities for medulloblastoma.
Analysis of survival data and late effects of therapy.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Related Experiment Videos

Last Updated: Feb 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Discussion of emerging treatment refinement strategies.

Main Results:

Survival rates for lower-risk medulloblastoma patients likely exceed 75%.
Significant progress in neuroimaging and surgical techniques has reduced mortality.
Radiation and chemotherapy regimens show increasing success, with ongoing trials.

Conclusions:

While survival has improved, minimizing late effects of treatment is crucial.
Reducing neuraxis radiation doses is a key goal, particularly for young patients.
Further treatment refinements are anticipated from ongoing cooperative group trials.